lntroduction: The latest improvements in the treatment of advanced testicular cancer hove been attributed to Cisplatinum based chemotherapy and surgery of retroperitoneal residual mass (RRMJ. The objective of this study is to analyze our experience and outcome of post-chemotherapy RRM surgery in advanced testicular cancer. Materials and Methods: Retrospective study of patients with surgery of post-chemotherapy RRM performed at the Urology Service of the University of Chile Clinic Hospital, from January 1988 to Oecember 2000. The surgical objective was the complete resection of the RRM. Results : 22 patients where analyzed with an average age of 26 year old. The size of the RRM varied between 1 and 17 cm. Thirteen patients where operated with normal tumor markers (TMJ levels and nine with high TM levels. A complete resection was done in 18 patients (82%). Seven patients presented major intra-surgical complications (32%] and 4 early post-surgical comp/ications (18%). There where no re-operations nor deaths in our series. Among the patients with normal TM levels, 3 presented active tumors in the RRM (25%); ali the patients with high TM levels presented active tumors in the RRM. Oiscussion: A high proportion of patients where operated with high
levels of tumor markers, including 5 surgeries that where previous/y programmed after 1 or 2
chemotherapy cycles. This type of surgery has high risks of complications . The histopathological findings depended on the primary histology and the preoperative TM.
Valdevenito, J. P. ., Merhe, . E. ., Valdevenito, R. ., Cuevas, M. A. ., Núñez, N. ., & Olea, M. . (2003). Cirugía de masas retroperitoneales residuales post quimioterapia en cáncer testicular. Revista Hospital Clínico Universidad De Chile, 14(2), pp. 132–40. https://doi.org/10.5354/2735-7996.2003.79391
